Imedex® is an industry leader in providing accredited, independent continuing medical education to health care professionals.
It is with great pleasure that we invite you to attend the 18th Annual Perspectives in Breast Cancer, a forum for leaders in breast cancer research and patient care to increase their knowledge and share their challenges and successes in disease management.
This conference has evolved into a dynamic educational forum to give practicing clinicians a comprehensive, one day update on new developments in breast cancer management through the latest data from society meetings, challenging cases, teaching lectures on special topics, and debates on current controversies. Topics for this year include ER-signaling in HER2-positive disease, treatment for very young breast cancer patients, growth factor pathways in hormone resistant cancers, neoadjuvant therapy for ER+ cancers, use of chemotherapy in HER2+ ER+ breast cancers, and the routine use of bisphosphonates.
Our panel of composed of leading researchers, medical oncologists, and breast cancer specialists will provide the latest information on state-of-the-art developments from the leading cancer centers and academic institutions.
Please join us in New York for what promises to be a rewarding and educational experience.
Ruth M. O'Regan, MD
Christy A. Russell, MD
|Discounted Registration Deadline||August 13, 2012|
|Presentation Dates||August 18, 2012|
11675 Rainwater Drive, Suite 600
Alpharetta, GA 30009, USA
Tel.: +1 (770) 751 7332
Fax: +1 (770) 751 7334
For registration inquiries:
Tel.: +1 (678) 242-0906
Toll-free (USA only): +1 (800) 233-0957
Fax: +1 (770) 751-7334
Imedex is Going Green!
In a continuing effort to be environmentally conscious Imedex will be offering speaker presentations online one week before the meeting begins. You can either download these presentations to your laptop or other electronic device or print them out and bring them onsite with you. A link to download the presentations will be emailed to you. Printed versions of the presentations will not be available onsite.